These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8359351)

  • 1. Biological activity of antibodies circulating in endocrine ophthalmopathy.
    Nauman JA
    Dev Ophthalmol; 1993; 25():29-37. PubMed ID: 8359351
    [No Abstract]   [Full Text] [Related]  

  • 2. Eye muscle cells in endocrine ophthalmopathy.
    Otto E; Krimmer U; Stover C; Beyer J; Kahaly G
    Dev Ophthalmol; 1993; 25():93-100. PubMed ID: 8359357
    [No Abstract]   [Full Text] [Related]  

  • 3. Graves' hyperthyroidism and endocrine ophthalmopathy--one or two closely related diseases?
    Volpé R
    Dev Ophthalmol; 1993; 25():101-11. PubMed ID: 8359344
    [No Abstract]   [Full Text] [Related]  

  • 4. Back to the drawing board for antigens in endocrine ophthalmopathy?
    Ludgate M
    Dev Ophthalmol; 1993; 25():86-92. PubMed ID: 7689491
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenetics of endocrine ophthalmopathy and Graves' disease.
    Badenhoop K; Schleusener H; Usadel KH
    Dev Ophthalmol; 1993; 25():11-9. PubMed ID: 8359345
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated anti-alpha-galactosyl antibody titres. A marker of progression in endocrine ophthalmopathy and in auto-immune thyroid disorders?
    Winand R
    Dev Ophthalmol; 1993; 25():38-45. PubMed ID: 8359352
    [No Abstract]   [Full Text] [Related]  

  • 7. Graves' disease: clinical correlation with autoantibody activity.
    Valente WA
    Md Med J; 1988 Nov; 37(11):866-9. PubMed ID: 3054388
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?
    van der Gaag R; Broersma L; Mourits MP; Koornneef L; Wiersinga WM; Prummel MP; Berghout A
    Clin Exp Immunol; 1989 Feb; 75(2):275-9. PubMed ID: 2649288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 10. Graves' ophthalmopathy: pathogenesis and clinical implications.
    Major BJ; Busuttil BE; Frauman AG
    Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.
    van der Gaag R; Vernimmen R; Fiebelkorn N; van Dierendonck MC; Kijlstra A
    Int Ophthalmol; 1990 Jan; 14(1):25-30. PubMed ID: 2182563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
    McLachlan SM; Bahn R; Rapoport B
    Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic aspects of thyroid disease.
    Riddick FA
    Ophthalmology; 1981 Jun; 88(6):471-5. PubMed ID: 6267533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Graves' enigma: breaking an immunological code.
    Jakobiec FA; Henkind P
    Ophthalmology; 1981 Jun; 88(6):26A-27A. PubMed ID: 6894970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
    Adler G
    Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I; Balázs C
    Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.